These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 20932595)
1. Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors. Syder AJ; Lee H; Zeisel MB; Grove J; Soulier E; Macdonald J; Chow S; Chang J; Baumert TF; McKeating JA; McKelvy J; Wong-Staal F J Hepatol; 2011 Jan; 54(1):48-55. PubMed ID: 20932595 [TBL] [Abstract][Full Text] [Related]
2. Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. Dreux M; Dao Thi VL; Fresquet J; Guérin M; Julia Z; Verney G; Durantel D; Zoulim F; Lavillette D; Cosset FL; Bartosch B PLoS Pathog; 2009 Feb; 5(2):e1000310. PubMed ID: 19229312 [TBL] [Abstract][Full Text] [Related]
3. Single amino acid mutation of SR-BI decreases infectivity of hepatitis C virus derived from cell culture in a cell culture model. Gao R; Gao W; Xu G; Xu J; Ren H World J Gastroenterol; 2017 Jul; 23(28):5158-5166. PubMed ID: 28811710 [TBL] [Abstract][Full Text] [Related]
4. Role of scavenger receptor class B type I in hepatitis C virus entry: kinetics and molecular determinants. Catanese MT; Ansuini H; Graziani R; Huby T; Moreau M; Ball JK; Paonessa G; Rice CM; Cortese R; Vitelli A; Nicosia A J Virol; 2010 Jan; 84(1):34-43. PubMed ID: 19828610 [TBL] [Abstract][Full Text] [Related]
6. High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI. Dreux M; Pietschmann T; Granier C; Voisset C; Ricard-Blum S; Mangeot PE; Keck Z; Foung S; Vu-Dac N; Dubuisson J; Bartenschlager R; Lavillette D; Cosset FL J Biol Chem; 2006 Jul; 281(27):18285-95. PubMed ID: 16675450 [TBL] [Abstract][Full Text] [Related]
7. Scavenger receptor class B type I mediates cell entry of hepatitis C virus. Jia ZS; Du DW; Lei YF; Wei X; Yin W; Ma L; Lian JQ; Wang PZ; Li D; Zhou YX J Int Med Res; 2008; 36(6):1319-25. PubMed ID: 19094442 [TBL] [Abstract][Full Text] [Related]
8. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. Voisset C; Callens N; Blanchard E; Op De Beeck A; Dubuisson J; Vu-Dac N J Biol Chem; 2005 Mar; 280(9):7793-9. PubMed ID: 15632171 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies. Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244 [TBL] [Abstract][Full Text] [Related]
10. High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein. Catanese MT; Graziani R; von Hahn T; Moreau M; Huby T; Paonessa G; Santini C; Luzzago A; Rice CM; Cortese R; Vitelli A; Nicosia A J Virol; 2007 Aug; 81(15):8063-71. PubMed ID: 17507483 [TBL] [Abstract][Full Text] [Related]
11. Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes. Barth H; Cerino R; Arcuri M; Hoffmann M; Schürmann P; Adah MI; Gissler B; Zhao X; Ghisetti V; Lavezzo B; Blum HE; von Weizsäcker F; Vitelli A; Scarselli E; Baumert TF J Virol; 2005 May; 79(9):5774-85. PubMed ID: 15827192 [TBL] [Abstract][Full Text] [Related]
12. Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells. Barth H; Schnober EK; Neumann-Haefelin C; Thumann C; Zeisel MB; Diepolder HM; Hu Z; Liang TJ; Blum HE; Thimme R; Lambotin M; Baumert TF J Virol; 2008 Apr; 82(7):3466-79. PubMed ID: 18216094 [TBL] [Abstract][Full Text] [Related]
13. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins. Bankwitz D; Vieyres G; Hueging K; Bitzegeio J; Doepke M; Chhatwal P; Haid S; Catanese MT; Zeisel MB; Nicosia A; Baumert TF; Kaderali L; Pietschmann T J Virol; 2014 Nov; 88(21):12644-55. PubMed ID: 25142595 [TBL] [Abstract][Full Text] [Related]
14. CD36 is a co-receptor for hepatitis C virus E1 protein attachment. Cheng JJ; Li JR; Huang MH; Ma LL; Wu ZY; Jiang CC; Li WJ; Li YH; Han YX; Li H; Chen JH; Wang YX; Song DQ; Peng ZG; Jiang JD Sci Rep; 2016 Feb; 6():21808. PubMed ID: 26898231 [TBL] [Abstract][Full Text] [Related]
15. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes. Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316 [TBL] [Abstract][Full Text] [Related]
16. The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination. Zahid MN; Turek M; Xiao F; Thi VL; Guérin M; Fofana I; Bachellier P; Thompson J; Delang L; Neyts J; Bankwitz D; Pietschmann T; Dreux M; Cosset FL; Grunert F; Baumert TF; Zeisel MB Hepatology; 2013 Feb; 57(2):492-504. PubMed ID: 23081796 [TBL] [Abstract][Full Text] [Related]
17. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Zeisel MB; Koutsoudakis G; Schnober EK; Haberstroh A; Blum HE; Cosset FL; Wakita T; Jaeck D; Doffoel M; Royer C; Soulier E; Schvoerer E; Schuster C; Stoll-Keller F; Bartenschlager R; Pietschmann T; Barth H; Baumert TF Hepatology; 2007 Dec; 46(6):1722-31. PubMed ID: 18000990 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals. Zhu H; Wong-Staal F; Lee H; Syder A; McKelvy J; Schooley RT; Wyles DL J Infect Dis; 2012 Feb; 205(4):656-62. PubMed ID: 22279172 [TBL] [Abstract][Full Text] [Related]
19. Hepatoma cell density promotes claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization. Schwarz AK; Grove J; Hu K; Mee CJ; Balfe P; McKeating JA J Virol; 2009 Dec; 83(23):12407-14. PubMed ID: 19776133 [TBL] [Abstract][Full Text] [Related]
20. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Anggakusuma ; Colpitts CC; Schang LM; Rachmawati H; Frentzen A; Pfaender S; Behrendt P; Brown RJ; Bankwitz D; Steinmann J; Ott M; Meuleman P; Rice CM; Ploss A; Pietschmann T; Steinmann E Gut; 2014 Jul; 63(7):1137-49. PubMed ID: 23903236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]